Zikani Therapeutics, Inc. — Form D

Zikani Therapeutics, Inc. of Watertown, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-16. The offering totals $7.5M, of which $7.5M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Sumit AggarwalDirectorWatertown, MA
Raj B Parekh, Ph.D.DirectorWatertown, MA
Christopher A ViehbacherDirectorWatertown, MA
Sumit AggarwalExecutive OfficerWatertown, MA
ANDREW MYERSDirectorSAN FRANCISCO, CA
Mary SzelaDirectorWestminster, CO
Raj ParekhDirectorWaltham, MA
Lawrence MillerDirectorAston, PA
Lawrence MillerExecutive OfficerAston, PA
Anja HarmeierDirectorBoston, MA
Christopher ViehbacherDirectorCambridge, MA
HENRY SKINNERDirectorSAN DIEGO, CA
Vikas GoyalDirectorBoston, MA
Markus GoebelDirectorSunnyvale, CA
Joseph ZakrzewskiDirectorWatertown, MA
Edward MascioliExecutive OfficerWatertown, MA
Andrew G LittlehaleExecutive OfficerWATERTOWN, MA
Henry G SkinnerDirectorWATERTOWN, MA
Monique G SciersingDirectorWATERTOWN, MA
Raj G ParekhDirectorWATERTOWN, MA
Andrew G MyersDirectorWATERTOWN, MA
Vikas G GoyalDirectorWATERTOWN, MA
Fereydoun G FirouzDirectorWATERTOWN, MA

Other filings by this issuer (3)

FiledFormOfferingSold
2018-03-13D$20.0M$12.0M
2016-04-29D/A$27.8M$12.2M
2015-02-25D$22.3M$8.2M

More